论文信息 - Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer. - 字舞流文

Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer.

Shing M. Lee | M. Maurer | D. Hershman | K. Crew | K. Kalinsky | M. Trivedi | M. Accordino | K. Fenn